News

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.
Thai healthcare solutions company Zuellig Pharma has announced that Mounjaro (tirzepatide), Eli Lilly’s (NYSE: LLY) ...
There has been a large increase in the number of unauthorised weight loss products seized by Revenue, according to the Health Products Regulatory Authority.
Russian drugmaker Geropharm has received a compulsory license from the Russian state to produce a generic of Ozempic ...
Jim Gaffigan shared his weight loss journey with Mounjaro, as he shed 50 pounds. Celebrities like Rosie O'Donnell and Amy ...
Viking Therapeutics faces tough obesity drug rivals, with VK2735 showing promise but an uncertain edge. Find out why VKTX ...
TruSkin’s newest launch, the SPF Serum, is getting rave reviews—4.8 stars on Amazon—and it’s easy to see why. As Dr. Marisa Garshick, a board-certified dermatologist, explains “It offers SPF 30 ...
Southeast Asian nations will forge a common front to face challenges including economic headwinds from U.S. tariffs and a ...
Adding to the pressure is that CVS Health has retained coverage of Zepbound's arch rival Wegovy (semaglutide), sold by Novo Nordisk, after negotiating a price cut with the company, along with Novo ...